ClinicalTrials.gg
RecruitingNCT07229079Updated Nov 17, 2025

The Effectiveness of Basic Body Awareness Therapy in Individuals With Pes Planus

An interventional study of Basic Body Awareness Therapy (BBAT) and Short Foot Exercises (SFE) in Pes Planus, sponsored by Mardin Artuklu University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-11-17.

Sponsored by Mardin Artuklu University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as recruiting.
  • Registered 10 months after the study started (first participant enrolled Jan 2025, registered Nov 2025).
  • Started Jan 2025; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This study investigates whether adding Basic Body Awareness Therapy (BBAT) to Short Foot Exercises (SFE) improves pes planus, balance, and body awareness in adults with flexible pes planus. Fifty participants aged 18-45 will be randomly assigned to either a BBAT + SFE group or an SFE-only control group. The interventions will last eight weeks with supervised sessions twice weekly and additional home exercises. Outcomes will be measured before, after, and two months post-intervention.

Read the detailed description

Pes planus is a common orthopedic condition characterized by the collapse of the medial longitudinal arch of the foot, which negatively affects lower extremity biomechanics, postural stability, and balance. Currently, interventions targeting muscle activation-such as short foot exercises (SFE)-are widely used in the management of pes planus. However, it is believed that holistic approaches incorporating sensory input and body awareness may further enhance functional outcomes in these individuals. Basic Body Awareness Therapy (BBAT) is a physiotherapeutic method designed to improve movement quality, balance, and posture. In this study, BBAT will be applied for the first time in individuals with pes planus. This project aims to investigate the effects of BBAT, when combined with SFE, on medial longitudinal arch height, foot function, gait, balance, proprioception, plantar sensation, and body awareness in individuals with pes planus. The study will be conducted as a randomized controlled trial. Fifty participants who meet the inclusion criteria will be randomly assigned into two groups of 25: a BBAT group (SFE + BBAT) and a control group (SFE only). Interventions will be administered twice a week for a duration of eight weeks. Assessments will be conducted at three time points: before the intervention, immediately after the eight-week intervention period, and two months post-intervention (follow-up). This study aims to demonstrate that BBAT can provide significant improvements in both somatic and sensory parameters in individuals with pes planus, offering a holistic complement to traditional exercise-based approaches. In doing so, it is expected to contribute an innovative perspective to clinical physiotherapy practices and address a significant gap in the existing literature.

02

Conditions studied

  • Pes Planus

Browse trials for

Keywords

  • Short Foot Exercises (SFE)
  • Basic Body Awareness Therapy (BBAT)
  • Pes Planus
  • Balance
  • Proprioception
  • Flatfoot
03

In context

Flatfoot

173 studies on the registry are indexed under Flatfoot; 44 are open to participants now.

This study's planned enrollment of 50 is above the median of 40 across 122 interventional studies indexed under Flatfoot.

Browse Flatfoot studies →

Lead sponsor

Mardin Artuklu University is the lead sponsor of 34 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-45 years
  • Willing to participate in the study
  • Flexible pes planus (Navicular Drop ≥10 mm and positive Jack's Toe Raise Test)

Exclusion criteria

Exclusion Criteria:

  • Pain in lower extremity joints
  • Obesity ( >30)
  • Pregnancy
  • Systemic, neuromuscular, or neurological disorders
  • Posterior tibial tendon dysfunction (unable to perform heel-rise test)
  • History of lower limb surgery
  • Previous treatment for pes planus or use of foot orthoses
  • Lower extremity injury in past 6 months
  • Orthopedic conditions other than pes planus and mild hallux valgus (Manchester Scale C or D excluded)
  • Participation in regular exercise program in past 6 months
  • Prior personal experience with TBFT and/or short foot exercises
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    BBAT Group

    Participants will receive Short Foot Exercises (SFE) plus Basic Body Awareness Therapy (BBAT).

    Behavioral: Basic Body Awareness Therapy (BBAT) · Behavioral: Short Foot Exercises (SFE)

  • Active comparator
    Control Group

    Participants will receive only Short Foot Exercises (SFE).

    Behavioral: Short Foot Exercises (SFE)

Interventions

  • BehavioralBasic Body Awareness Therapy (BBAT)

    Participants will perform Basic Body Awareness Therapy (BBAT) combined with SFE for 8 weeks. BBAT sessions are 45 minutes, twice weekly in small groups under a certified physiotherapist. Exercises target postural control, motor coordination, body awareness, balance, and functional movement, progressing from supine to sitting, standing, and walking positions. After each BBAT session, participants perform SFE following the same progression as the Control Group.

  • BehavioralShort Foot Exercises (SFE)

    Participants will perform Short Foot Exercises (SFE) for 8 weeks. Sessions are twice weekly under physiotherapist supervision in small groups (3-8 participants) and 5 days/week at home. Exercises progress from sitting (weeks 1-2), standing (weeks 3-4), single-leg (weeks 5-6), to functional activities (weeks 7-8). Each session lasts \~20 minutes, 3 sets of 10 reps with 1-minute rest. Participants receive instruction on proper technique and adherence is monitored online

06

What researchers measure

Primary outcomes

  1. Navicular Drop Test

    Assessment of medial longitudinal arch height to determine presence and severity of pes planus. Test performed in both sitting (non-weight-bearing) and standing (weight-bearing) positions. Difference ≥10 mm indicates pes planus.

    Time frame: Baseline (pre-intervention), post-intervention (8 weeks), follow-up (2 months after intervention)

  2. Dynamic Balance

    Y Balance Test measuring reach distance in anterior, posteromedial, and posterolateral directions. Results normalized to leg length.

    Time frame: Baseline, post-intervention (8 weeks), follow-up (2 months)

  3. Proprioception

    Active and passive joint position sense of the ankle measured with digital goniometer. Eyes closed; angular error from target angle recorded.

    Time frame: Baseline, post-intervention (8 weeks), follow-up (2 months)

  4. Light Touch Sensation

    Semmes-Weinstein Monofilament Test at seven foot reference points. Threshold of sensation recorded.

    Time frame: Baseline, post-intervention (8 weeks), follow-up (2 months)

Secondary outcomes

  1. Foot Function Index - Pain Subscale

    The Pain subscale of the Foot Function Index (FFI) assesses foot pain during daily activities. It includes 9 items rated on a 0-10 Likert-type scale. Higher scores indicate worse pain.self-rate 23 items using a visual analog scale.

    Time frame: Baseline, post-intervention (8 weeks), follow-up (2 months)

  2. Foot Function Index - Disability Subscale

    The Disability subscale of the Foot Function Index (FFI) evaluates difficulty in performing functional activities. It contains 9 items scored on a 0-10 Likert-type scale. Higher scores indicate greater disability.

    Time frame: Baseline, post-intervention (8 weeks), follow-up (2 months)

  3. Foot Function Index - Activity Limitation Subscale

    The Activity Limitation subscale of the Foot Function Index (FFI) measures limitations in essential daily activities. It consists of 5 items rated on a 0-10 Likert-type scale. Higher scores indicate greater activity limitation.

    Time frame: Baseline, post-intervention (8 weeks), follow-up (2 months)

  4. Foot Function Index - Total Score

    The Total Score of the Foot Function Index (FFI) is calculated by combining all pain, disability, and activity limitation items (23 items in total). Each item is rated on a 0-10 Likert-type scale. The total score reflects the overall foot-related functional status, with higher scores indicating worse function.

    Time frame: Baseline, post-intervention (8 weeks), follow-up (2 months)

  5. Static Balance

    Flamingo Balance Test. Participant stands on one leg on a narrow beam for 1 minute; balance errors recorded.

    Time frame: Baseline, post-intervention (8 weeks), follow-up (2 months)

  6. Gait Performance

    10-Meter Walk Test performed at comfortable walking speed. Time recorded and averaged over three trials.

    Time frame: Baseline, post-intervention (8 weeks), follow-up (2 months)

  7. Body Awareness

    Body Awareness Questionnaire assessing participant's perception of bodily sensations and processes. Score range 18-126; higher scores indicate better awareness.

    Time frame: Baseline, post-intervention (8 weeks), follow-up (2 months)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Nov 2025, 10 months after the start.

Of 89 non-industry interventional studies with no phase under Flatfoot, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 15. This study's planned 10 months is above that.

Counting every sponsor, half of 89 studies reached it within 7 months; a quarter within 2 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2025
First posted
Nov 14, 2025
StartActual
Jan 1, 2025
Primary completionEst.
Nov 2025
CompletionEst.
Dec 2025
Last update
Nov 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07229079
Lead sponsor
Mardin Artuklu University
Responsible party
Fatma Betül YARDIMCI (RESEARCH ASSISTANT, Mardin Artuklu University) — Principal investigator
First posted
Nov 14, 2025
Start date
Jan 1, 2025
Primary completion
Nov 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Nov 17, 2025

Study contacts

Fatma Betül Yardımcı
Contact
fatmabetulyardimci@gmail.com
+905063196665
Bahar Anaforoglu
Contact
anaforoglub@hotmail.com
+905057421220
Fatma Betül Yardımcı, MSc
principal investigator · Mardin Artuklu University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion